JPS4861621A - - Google Patents

Info

Publication number
JPS4861621A
JPS4861621A JP47114317A JP11431772A JPS4861621A JP S4861621 A JPS4861621 A JP S4861621A JP 47114317 A JP47114317 A JP 47114317A JP 11431772 A JP11431772 A JP 11431772A JP S4861621 A JPS4861621 A JP S4861621A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP47114317A
Other languages
Japanese (ja)
Other versions
JPS5512002B2 (en:Method
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4861621A publication Critical patent/JPS4861621A/ja
Publication of JPS5512002B2 publication Critical patent/JPS5512002B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1235—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP11431772A 1971-11-17 1972-11-16 Expired JPS5512002B2 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2157148A DE2157148A1 (de) 1971-11-17 1971-11-17 Immunisierungsmittel, verfahren zur herstellung und seine verwendung

Publications (2)

Publication Number Publication Date
JPS4861621A true JPS4861621A (en:Method) 1973-08-29
JPS5512002B2 JPS5512002B2 (en:Method) 1980-03-29

Family

ID=5825419

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11431772A Expired JPS5512002B2 (en:Method) 1971-11-17 1972-11-16

Country Status (10)

Country Link
JP (1) JPS5512002B2 (en:Method)
AT (1) AT332539B (en:Method)
BE (1) BE791489A (en:Method)
CH (1) CH588867A5 (en:Method)
DD (1) DD102410A5 (en:Method)
DE (1) DE2157148A1 (en:Method)
FR (1) FR2160542B1 (en:Method)
GB (1) GB1416544A (en:Method)
NL (1) NL7215221A (en:Method)
SE (1) SE406419B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6230729A (ja) * 1985-05-04 1987-02-09 ビオテスト、フアルマ、ゲゼルシヤフト、ミツト、ベシユレンクテル、ハフツンク 多価高度免疫グロブリン製剤およびその製法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10331974A1 (de) * 2003-07-14 2005-02-17 Uni-Klinikum Schleswig-Holstein Campus Kiel Verfahren zur Herstellung und Verwendung antimikrobielle Proteine induzierender Faktoren
RU2683027C2 (ru) * 2012-12-20 2019-03-26 Заклад Бадавчо-Вдроженёвы Осьродка Сальмонельля "Иммуноляб" Сп. З О.О. Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1468630A (fr) * 1963-03-14 1967-02-10 Taisho Pharmaceutical Co Ltd Préparation du lipide alpha purifié à partir de lipide alpha brut dérivé des lipopolysaccharides de bactéries à gram-négatif

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6230729A (ja) * 1985-05-04 1987-02-09 ビオテスト、フアルマ、ゲゼルシヤフト、ミツト、ベシユレンクテル、ハフツンク 多価高度免疫グロブリン製剤およびその製法

Also Published As

Publication number Publication date
FR2160542B1 (en:Method) 1976-04-23
AU4902772A (en) 1974-05-23
JPS5512002B2 (en:Method) 1980-03-29
AT332539B (de) 1976-10-11
CH588867A5 (en:Method) 1977-06-15
FR2160542A1 (en:Method) 1973-06-29
SE406419B (sv) 1979-02-12
ATA975872A (de) 1976-01-15
DE2157148A1 (de) 1973-05-24
BE791489A (fr) 1973-05-16
GB1416544A (en) 1975-12-03
NL7215221A (en:Method) 1973-05-21
DD102410A5 (en:Method) 1973-12-12

Similar Documents

Publication Publication Date Title
FR2122202A5 (en:Method)
AU477054B2 (en:Method)
FR2124464B1 (en:Method)
FR2125426B1 (en:Method)
FR2121738B3 (en:Method)
DK136431C (en:Method)
FR2124255A1 (en:Method)
FR2126674A5 (en:Method)
FR2126269B1 (en:Method)
FR2122823A5 (en:Method)
DE2139381A1 (en:Method)
FR2122557A1 (en:Method)
FR2160542B1 (en:Method)
DE2105638C3 (en:Method)
CS170193B2 (en:Method)
AU2691671A (en:Method)
FR2127386A5 (en:Method)
FI50174B (en:Method)
FI50478B (en:Method)
FR2122264A5 (en:Method)
DE2100987A1 (en:Method)
DE2163845A1 (en:Method)
CS154429B1 (en:Method)
CS152629B1 (en:Method)
CS165807B1 (en:Method)